Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry

Daclizumab beta is a humanized monoclonal antibody that binds to CD25 and selectively inhibits high-affinity IL-2 receptor signaling. As a former treatment for relapsing forms of multiple sclerosis (RMS), daclizumab beta induces robust expansion of the CD56bright subpopulation of NK cells that is co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	bioRxiv
Hauptverfasser:	Ranganath, Thanmayi, Simpson, Laura Jane, Seiler, Christof, Ferreira, Anne-Maud, Vendrame, Elena, Zhao, Nancy Q, Fontenot, Jason D, Holmes, Susan P, Blish, Catherine A
Format:	Paper
Sprache:	Englisch
Veröffentlicht:	Cold Spring Harbor Cold Spring Harbor Laboratory Press 05.12.2019 Cold Spring Harbor Laboratory
Ausgabe:	1.1
Schlagworte:	CD25 antigen CD56 antigen CD57 antigen Cytometry Histocompatibility antigen HLA Immunology Immunomodulation Interleukin 2 Interleukin 2 receptors Lymphocytes T Monoclonal antibodies Multiple sclerosis Natural killer cells NKG2 antigen Perforin Phenotypes
ISSN:	2692-8205, 2692-8205
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!